The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

“These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...